Grant: Master's Award: Canada Graduate Research Scholarships - Master's program
University of British Columbia
$27,000.00
Molecular mechanisms of lung cancer development in former smokers
FY 2025-26
Summary
Lung cancer is often diagnosed at late stages, with limited treatment options and poor survival outcomes. While smoking cessation lowers risk, approximately half of all new lung cancer cases occur in former smokers. As a result, lung cancer will remain a major public health challenge for years to come. Currently, 23.2% of Canadians (>7 million people) identify as former smokers. Our research investigates why some former smokers develop lung cancer while others remain cancer-free, despite similar smoking histories. We will analyze rare airway epithelial samples of patients with >20 years of follow-up outcome data to identify persistent changes in DNA methylation—a mechanism that can silence tumor-suppressor genes—and reveal gene regulation patterns linked to early carcinogenesis. We aim to improve risk prediction, enable earlier detection, and uncover new targets, potentially benefiting millions who have quit smoking yet still face uncertainty about their cancer risk.
Department
Program
Master's Award: Canada Graduate Research Scholarships - Master's program
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
573188
Name
Benard Katya H
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Molecular mechanisms of lung cancer development in former smokers
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Dna Methylation; Early Detection; Field Cancerization; Genomic Profiling; Lung Cancer; Lung Carcinogenesis; Persistent Molecular Alterations; Precision Prevention; Risk Stratification; Smoking Cessation
Abstract
Lung cancer is often diagnosed at late stages, with limited treatment options and poor survival outcomes. While smoking cessation lowers risk, approximately half of all new lung cancer cases occur in former smokers. As a result, lung cancer will remain a major public health challenge for years to come. Currently, 23.2% of Canadians (>7 million people) identify as former smokers. Our research investigates why some former smokers develop lung cancer while others remain cancer-free, despite similar smoking histories. We will analyze rare airway epithelial samples of patients with >20 years of follow-up outcome data to identify persistent changes in DNA methylation—a mechanism that can silence tumor-suppressor genes—and reveal gene regulation patterns linked to early carcinogenesis. We aim to improve risk prediction, enable earlier detection, and uncover new targets, potentially benefiting millions who have quit smoking yet still face uncertainty about their cancer risk.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Benard, Katya H
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~